A New Era of Biotech: The Rise of Scalable Life Science Platforms
Jonas Kochen Jonas Kochen

A New Era of Biotech: The Rise of Scalable Life Science Platforms

The Life Science industry is shifting from a linear, molecule-focused model to scalable, data-driven platforms powered by AI and computable biology. Success now depends less on the science alone and more on the ability to build systems that connect, learn, and scale globally. Future leaders will be platform-based companies that compound data over time, with value concentrated in areas like AI-native biology, clinical networks, and precision medicine. The key advantage is no longer the molecule itself, but the intelligence layer around it—patient selection, delivery, and real-world evidence.

Read More